Introduction of the pneumococcal conjugate vaccine in humanitarian and fragile contexts: Perspectives from stakeholders in four African countries

Baldeep K. Dhaliwala International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAView further author information

Rose Weeksa International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAView further author information

Jasmine Hubera International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAView further author information

Aminata Fofanaa International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USAView further author information

Mohamed Bobeb Somalia/Somaliland Country Office, Save the Children, Mogadishu, SomaliaView further author information

Antoinette Demian Mbailamenc Programme Elargi de Vaccination, Ministère de la Santé Publique, N’Djamena, ChadView further author information

George Legged Expanded Programme on Immunisation (EPI), National Ministry of Health, Juba, Republic of South Sudan;e Expanded Programme on Immunisation (EPI), Ministry of Health and Public Hygiene, Conakry, Republic of GuineaView further author information

Gassim Cissee Expanded Programme on Immunisation (EPI), Ministry of Health and Public Hygiene, Conakry, Republic of GuineaView further author information

Anita Sheta International Vaccine Access Center, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USACorrespondence[email protected]
View further author information

show all

Introduction of the pneumococcal conjugate vaccine in humanitarian and fragile contexts: Perspectives from stakeholders in four African countries

Supplemental Material

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Introduction of the pneumococcal conjugate vaccine in humanitarian and fragile contexts: Perspectives from stakeholders in four African countries

Supplemental Material

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date